United States· US:0990-7109_11a3a5e5-57e6-49b9-bed9-c4db277a38be
Potassium Chloride in Dextrose and Sodium Chloride
A medicinal product containing dextrose monohydrate; sodium chloride; potassium chloride, registered in United States by ICU Medical Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE
- Manufacturer
- ICU Medical Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110990-7109-09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dadb5e14-0489-47fc-935d-4d6a2d294368 GET /v1/drugs/dadb5e14-0489-47fc-935d-4d6a2d294368?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "50; 9; 2.98",
"substance": "DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE",
"productndc": "0990-7109",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1000mL; g/1000mL; g/1000mL",
"application_number": "NDA019691",
"marketing_category": "NDA"
}See everything about dextrose monohydrate; sodium chloride; potassium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.